Abstract
The incidence of new end-stage renal disease (ESRD) is gradually increasing because of increasing awareness about renal problems and greater availability of treatment facilities for this condition. In India itself it is reported that the incidence of new ESRD patients varies between 80 and 100/1 million population every year. However, the choice of treatment of ESRD depends on various non-medical factors such as the financial situation of the family, availability of a family donor for transplant, social and cultural habits, availability of facilities for dialysis and last but not least on the preference of the treating nephrologist. In most developing countries facilities for maintenance haemodialysis are limited and a cadaveric transplantation programme is yet to become a reality. There are only 0.3 haemodialysis centred/million population in India for maintenance haemodialysis [1]. The socioeconomic statuses of the various regions of the world are diverse and the gross domestic product (GDP) and per-capita income is low in the developing countries. In India the average per-capita income is US$500 per year. Even today 75% of the dialysis resources are reserved for only 15% of the world’s poulation, and in many countries the sole alternative to dialysis or transplantation is death [2]. In large areas of Africa, Latin America, the Indian subcontinent and Southeast Asia, renal replacement therapy for renal failure is poorly developed and is affordable for only a small minority. The policies for treatment of patients with ESRD vary greatly from the developed to the developing world. This is largely based on government and medical insurance reimbursement policies, type of renal replacement therapy (RRT) done, and physician incentive to introduce peritoneal dialysis as an equal or better alternative form to haemodialysis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Sakhuja V, Jha V, Ghosh AK et al Chronic renal failure in India. Nephrol Dial Transplant 1994; 9: 871–2.
Maiorca R, Maggiore R, Mordacci E et al Ethical problems in dialysis and transplantation. Nephrol Dial Transplant 1996; 11 (suppl. 9): 100–12.
Rashid HU, Azhar MA, Rahman A. Management of end stage renal disease with intermittent peritoneal dialysis. Petit Dial Bull 1986; 6: 214.
Trevino-Becerra A. Intermittent peritoneal dialysis with a cycler may be the answer. Petit Dial Bull 1984; 4: 112.
Tripathi K, Jai Prakash. Peritoneal dialysis in post-abdominal surgery in elderly patients developing acute renal failure. Petit Dial Bull 1987; 7: S78.
Cheng IK. Peritoneal dialysis in Asia. Petit Dial Int 1996; 16 (suppl. 1): S381–5.
Abraham G, Bhaskaran S, Soundarajan P et al Continuous ambulatory peritoneal dialysis. J Assoc Phys India 1996; 44: 599–601.
Samad MA. CAPD: experience in Bangladesh. Petit Dial Int 1998; 18 (suppl. 2): S24.
Rizvi SAH. Present state of dialysis and transplantation in Pakistan. Am J Kidney Dis 1998; 31: x/v-x/viii.
Su-Hernandez L, Abascal Macias A, Mendez Bueno FJ et al Epidemiologic and demographic aspects of peritoneal dialysis in Mexico. Petit Dial Int 1996; 16: 362–5.
Gamba G, Mejia JL, Saldivav S et al Death risk in CAPD patients. The predictive values of the initial clinical and laboratory variables. Nephron 1993; 65: 23–7.
Espinoso A, Cueto Manzano AM, Velazquez Alva C et al Prevalence of malnutrition in Mexican CAPD diabetic and nondiabetic patients. Adv Petit Dial 1996; 12: 302–6.
Leanos Miranda A. Factors predicting survival in patients on peritoneal dialysis. Rev Invest Clin 1997; 49: 355–60.
Thome FS, Rodrigues AT, Bruno R et al CAPD in southern Brazil: an epidemiological study. Adv Petit Dial 1997; 13: 141–5.
Sesso R, Eisenberg JM, Stabile C et al Cost effectiveness analysis of the treatment of end stage renal disease in Brazil. Int J Technol Assess Health Care 1990;. S6: 107–14.
Ramirez JA, Ruiz S, Ferraris T et al Continuous ambulatory peritoneal dialysis (CAPD): an alternative for the treatment of children with terminal chronic renal insufficiency in Argentina. Bol Med Hosp Infant Mex 1991; 48: 140–3.
Alves FR, Dantas RC, Lugon JR. Higher incidence of catheter related infections in a tropical climate. Adv Petit Dial 1993; 9: 244–7.
Cendoroglo Neto M, Draibe SA, Silva AE et al Incidence of and risk factors for hepatitis B virus and hepatitis C virus infection among haemodialysis and CAPD patients: evidence for envoronmental transmission. Nephrol Dial Transplant, 1995; 10: 240–6.
Vanderborght BO, Rouzere C, Ginuino CF et al High prevalence of hepatitis C infection among Brazilian haemodialysis patients in Rio de Janeiro: a one year follow up study. Rev Inst Med Trop Sao Paulo, 1995; 37: 75–9.
Fierro JA, Gomez E, Labbe E et al Peritoneal dialysis new ESRD treatment in Chile. Petit Dial Int 1998; 18 (suppl. 2): S19.
Amair P, Betancor J, Weisenger JR. Comparison between CAPD and haemodialysis (HD) mortality rates. Petit Dial Int 1998; 18 (suppl. 2): S17.
Rutkowski B, Lichodziejewska-Niemeierko M, Reneke M et al Current status of peritoneal dialysis (PD) in Poland. Peril Dial Int 1998; 18 (suppl. 2): S14.
Lazovkis I. Nephrology, dialysis and renal transplantation in Latvia: problems of our speciality in a country of the former Soviet block. Nephrol Dial Transplant 1994; 9: 214–16.
Petersons A, Ritz E. Nephrology in the Baltic countries. Nephrol Dial Transplant 1998; 13: 2779–80.
al-Hilali N, Cozma G, Abu Romesh S et al Incidence of peritonitis on CAPD in Kuwait APMIS Suppl. 1988; 3: 101–3.
Benjamin J, Ben Ezer Gradus D, Mostoslayski M et al Peritonitis in continuous ambulatory peritoneal dialysis patients in Southern Israel. Isr J Med Sci 1989; 25: 699–702.
Chiou YY, Chen WP, Yang LY, Lin CY. Peritonitis in children being treated with continuous ambulatory peritoneal dialysis. CAPD Team Chung Hua Min Kuo Hsiao Erh Ko L Hsueh Hui Tsa Chth 1995; 36: 176–83.
Gahrmani N, Gorban Brennan N, Kliger AS, Finkelstein FO. Infection rates in end stage renal disease patients treated with CCPD and CAPD using the ultra bag system. Adv Peril Dial. 1995; 11: 164–7.
Lee GS, Woo KT. Infection in continuous ambulatory peritoneal dialysis (CAPD): etiology, complications and risk factors. Ann Acad Med Singapore 1992; 21: 354–60.
Annigeri RA, Prakash GK, Balasubramaniyam R et al. `O’ set connector system in CAPD. J Assoc Phys India 1996; 44: 602–5.
Nitedvoravit S, Sivivongs D, Chunleritrith D. Outcome of peritonitis in CAPD in a Thai Medical centre. Peril Dial Int 1998; 18 (suppl. 2): S78.
Dai J, Hu Y, Zheng ZH. Nursing care can improve quality of dialysis in CAPD patients Petit Dial Int 1998; 18 (suppl. 2): 546.
Han QF, Fan MH. Five years’ peritoneal dialysis experience in China. Peril Dial Int 1998; 18 (suppl. 2): S19.
Konomopoulos D, Dombros N, Balaskas E et al Survival and complications of 103 catheters used in CAPD and intraperitoneal chemotherapy. Petit Dial Int 1998; 8: 75.
Kim JK, Shin YH, Park YK et al Clinical observation of CAPD and HD patients. Petit Dial Int 1998; 18 (suppl. 2): S19.
Alwi K, Dwarkanathan R, Chin S, Chin LS, Krishnan Aung. CAPD: is it an adequate therapy for end stage renal patients in developing countries? Petit Dial Int 1988; 18: S28.
el-Matti A, Ben Abdallah T, Kechrid C et al Continuous ambulatory peritoneal dialysis in Tunisia. Nephrologie 1990; 11: 153–6.
Salahudeen AK, D’Costa K, Pingle A. Successful experience with CAPD in UAE. Peril Dial Bull 1987; 7: S66.
Agastini L, Leon L, Rojas M. Treatment with CAPD for 54 months of a patient with end stage renal disease due to multiple myeloma. Petit Dial Bull 1986; 6: 46.
Drinovec J, Bren A, Gucek A et al. 42 months overview of CAPD peritonitis in one center. Peril Dial Bull 1987; 7: S26.
Laradi A, Krowri A, Drif M. Management of a CAPD program in developing country - an Algerian perspective. Petit Dial Int 1988; 8: 84.
Balista AV, Dangilan RA. The prevalence of peritonitis in renal patients on CAPD. Petit Dial Int 1998; 18 (suppl. 2): S78.
Henao JE, Meija G, Arbelaez M et al Six and a half years of experience with three two liter daily exchanges in CAPD. Petit Dial Int 1988; 8: 207–10.
Jankroic N, Varlaj V, Pavloic D. The morbidity and mortality rate in CAPD patients. Petit Dial Int 1998; 18: S82.
Lye WC, Van der Straaten JC, Leong SO et al Once daily intraperitoneal gentamycin is effective therapy for Gram negative CAPD peritonitis. Petit Dial Int 1998; 18 (suppl. 2): S74.
Chan MK, Chan PC, Cheng IP et al Pseudomonas peritonitis in CAPD patients: characteristics and outcome of treatment. Nephrol Dial Transplant 1989; 4: 814–7.
Szeto CC, Li PK, Leung CB et al. Xanthomonas maltophilia in uremic patients receiving ambulatory peritoneal dialysis. Am J Kidney Dis 1997; 29: 91–5.
Lye WC, Leong SO, vander Straaten JC, Lee EJ. A prospective study of peritoneal dialysis related infections in CAPD patients with diabetes mellitus. Adv Petit Dial 1993; 9: 195–7.
Locatlli A, Quiroga MA, De Benedetti L et al Treatment of recurrent and resistant CAPD peritonitis by temporary withdrawal of peritoneal dialysis without removal of the catheter. Adv Petit Dial 1995; 11: 176–8.
Park MS, Yim AS, Chung SH et al Effect of prolonged subcutaneous implantation of peritoneal catheter on peritonitis rate during CAPD: a prospective randomized study. Blood Purif 1998; 16: 171–8.
Han DC, Cha HK, So IN et al Subcutaneously implanted catheters reduce the incidence of peritonitis during CAPD by eliminating infection by periluminal route. Adv Petit Dial 1992; 8: 298–301.
Gupta A. Fungal and bacterial infection in peritoneal dialysis. Personal communication.
Ishizaki M, Oikawa K, Miyashita E. Usefulness of the endotoxin test for assessing CAPD peritonitis by gram negative organisms. Adv Petit Dial 1996; 12: 199–202.
Yang CW, Hwang TL, Wu CH et al Peritoneal nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1996; 11: 2466–71.
Dutta AR, Choudhary S. Oral ciprofloxacin and intraperitoneal gentamycin: effective and cheap therapy for peritonitis. Petit Dial Int 1998; 18 (suppl. 2): S75.
Cheng IK, Chan CY, Wong WT et al A randomized prospective comparison of oral versus intraperitoneal ciprofloxacin as the primary treatment of peritonitis complicating continuous ambulatory peritoneal dialysis. Petit Dial Int 1993; 13 (suppl. 2): S351–4.
Hwang TL, Huang CC. Comparison of swan-neck catheter with Tenckhoff catheter for CAPD. Adv Petit Dial 1994; 10: 203–5.
Lye WC, Kour NW, Van der Straten JC et al A prospective randomized comparison of the Swan neck, coiled and straight Tenckhoff catheters in patients on CAPD. Petit Dial Int 1996; 16 (suppl. 1): S333–5.
Yeh TJ, Wei CF, Chiu TW. Catheter related complications of continuous ambulatory peritoneal dialysis. Eur J Surg 1992; 158: 277–9.
Lee WC, Lee EJ, Tan CC. Prophylactic antibiotics in the insertion of Tenckhoff catheters. Scand J Urol Nephrol 1992; 26: 177–80.
Lye WE, Giang MM, Vander Straaten JC, Lee EJ. Breaking in after insertion of Tenckhoff catheters: a comparison of two techniques. Adv Petit Dial 1993; 9: 236–9.
Tanaka S. Sealing the catheter exit site with dressing film and its effectiveness in preventing exit site infection: bacterial culture. Adv Petit Dial 1996; 12: 214–17.
Shino T, Okade T, Matsumoto H, Nakao T. Ineffectiveness of disinfectant treatment using povidone iodine in the prevention of exit site infection in peritoneal dialysis. Petit Dial Int 1998; 18 (suppl. 2): S37.
Kim JH, Park SH, Kim JC et al Outcome of external cuff shaving for persistent exit site infection in CAPD. Petit Dial Int 1998; 18 (suppl. 2): S15.
Thiruventhiran T, Fitzgerald GH, Tan SY. Catheter cuff shaving procedure: description of a novel technique using the common catheter. Petit Dial Int 1998; 18 (suppl. 2): S16.
Chan TM, Chan CY, Cheng SW et al Treatment of fungal peritonitis complicating ambulatory peritoneal dialysis with fluconazole: a series of 21 patients. Nephrol Dial Transplant 1994; 9: 539–42.
Wang AYM, Yu AWY, Li PKT et al An analysis of a nine-year trend of fungal peritonitis in CAPD patients. Petit Dial Int 1998; 18 (suppl. 2): S75.
Manjari M, Abraham G, Sekhar U et al Outcome of patients on CAPD with fungal peritonitis. Ind J Petit Dial 1998; 1: 37–9.
Zhu Z, Zhang W, Yang X et al The factors related to fungal peritonitis in patients on peritoneal dialysis. J Tongji Med Univ 1997; 17: 123–5.
Cheng IK, Fang GX, Chan TM, Chan PC, Chan MK. Fungal peritonitis complicating peritoneal dialysis: a report of 25 cases and review of treatment. Q J Med 1989; 71: 407–16.
Lopes JO, Alves SH, Benevenga JP, Rosa AL. The second case of peritonitis due to Histoplasma capsulatum. Mycoses 1994; 37: 161–3.
Chan TH, Koehler A, Li PK. Paecilomyces varioti peritonitis in patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1996; 27: 138–42.
Lee SH, Chiang SS, Hseih SJ, Shen HM. Intra catheter amphotericin B retention for fungal peritonitis in continuous ambulatory peritoneal dialysis. J Formos Med Assoc 1995; 94: 132–4.
Lo WK, Chan CY, Cheng SW, Poon JF. A prospective randomized control study of oral nystatin prophylaxis for Candida peritonitis complicating continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1996; 28: 549–52.
Lui SL, Lo CY, Choy BY et al Optimal treatment and long term outcome of tuberculous peritonitis complicating continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1996; 28: 747–51.
Vathsala A, Thomas A, Ng BL, Lim CH. An unusual case of peritonitis. An Acad Med Singapore 1987; 16: 666–70.
Tsai TC, Hsu JC, Chou LH, Lee ML. Tuberculous peritonitis in a child undergoing continuous ambulatory peritoneal dialysis. Chung Hua Min Kuo Hsiao Erh Ko L Hseuh Hui Tsa Chih. 1994; 35: 455–9.
Aparajitha C, Abraham G, Sekhar U et al Tuberculosis in a cohort of CAPD population. Petit Dial Int 1998; 18 (suppl. 2): S37.
Zimmerman S, Abraham G. Was CAPD the answer to the patient’s complex problems? Petit Dial Int 1997; 17: 630–6.
Bastani B, Shariatzadeh MR, Dehdasthi F. Tuberculous peritonitis: report of 30 cases and review of literature. Q J Med 1985; 56: 549–57.
Fernandez-Rodriguez CM, Perez-Arguelles BS, Ledo L et al Ascitic adenosine deaminase activity is decreased in tuberculous ascites with low protein content. Am J Gastroenterol 1991; 86: 1500–3.
Singh MM, Bhargava AN, Jain KP. Tuberculous peritonitis: an evaluation of pathogenic mechanism, diagnostic procedures and therapeutic measures. N Engl J Med 1969; 281: 1091–4.
Mallet SG, Brensitner JM. Tuberculous peritonitis in a CAPD patient cured without catheter removal - case report, review of the literature and guidelines for treatment and diagnosis. Am J Kidney Dis 1989; 13: 57.
Tan D, Fein PA, Jorden A, Avram MM. Successful treatment of tuberculous peritonitis while maintaining patient on CAPD. Adv Petit Dial 1991; 7: 102–4.
Vas SI. Renaissance of tuberculosis in the 1990’s. Lessons for the nephrologist. Petit Dial Int 1994; 14: 209–14.
Keane WF, Alexander SR, Baile GR et al Peritoneal dialysis related peritonitis, treatment recommendations 1996 update. Petit Dial Int 1996; 16: 557–73.
Dunmire RB, Breyer JA. Nontuberculous mycobacterial peritonitis during continuous ambulatory peritoneal dialysis: case report and review of diagnostic and therapeutic strategies. Am J Kidney Dis 1991; 18: 126–30.
Hung KY, Shyu RS, Huang CH, Tsai TJ, Chen WY. Viral hepatitis in continuous ambulatory peritoneal dialysis patients in an endemic area for hepatitis B and C infection: the Taiwan experience. Blood Purif 1997; 15: 195–9.
Hung KY, Shyu RS, Tsai TJ, Chen WY. Viral hepatitis infection should be considered for evaluating uremic pruritis in continuous ambulatory peritoneal dialysis patients. Blod Purif 1998; 16: 147–53.
Hung KY, Lee KC, Yen CJ et al Revised cutoff values of serum aminotransferase in detecting viral hepatitis among CAPD patients: experience from Taiwan, an endemic area for hepatitis B. Nephrol Dial Transplant 1997; 12: 180–3.
Huang CC, Wu MS, Lin DY, Liaw YF. The prevalence of hepatitis C virus antibodies in patients treated with continuous ambulatory peritoneal dialysis. Petit Dial Int 1992; 12: 31–3.
Chan TM, Lok AS, Cheng IK. Hepatitis C infection among dialysis patients: a comparison between patents on maintenance haemodialysis and continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1991; 6: 944–7.
Lee HY, Kang DH, Park CS et al Comparative study of hepatitis C virus antibody between haemodialysis and continuous ambulatory peritoneal dialysis patients. Yon sei Med J 1993; 34: 371–80.
Ng YY, Lee SD, Wu SC et al Antibodies to hepatitis C virus in uremic patients on continuous ambulatory peritoneal dialysis. J Med Virol 1991; 35: 263–6.
Lee GS, Roy DK, Fan FY et al Hepatitis C antibodies in patients on peritoneal dialysis: prevalence and risk factors. Petit Dial Int 1996; 16 (suppl. 1): S424–8.
al-Mugeiren M, al-Rasheed S, al-Sallum A et al Hepatitis C virus infection in two groups of pediatric patients: one maintained on hemodialysis and the other on continuous ambulatory peritoneal dialysis. Ann Trop Pediatr 1996; 16: 335–9.
Nakashima F, Sate M, Takeshi S et al Incidence of antibodies to hepatitis C virus in patients undergoing chronic dialysis or CAPD. Murume Med J 1993; 40: 249–53.
Ng YY, Lee SD, Wu SC et al The need for second generation anti-hepatitis C virus testing in uremic patients on continuous ambulatory peritoneal dialysis. Petit Dial Int 193; 13: 132–5.
Huang CH, Kao JH, Kuo YM et al GB virus C/hepatitis G virus infection in patients on continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1988; 13: 2914–19.
Noh H, Kang SW, Choi SH et al Hepatitis G virus infection in hemodialysis and continuous ambulatory peritoneal dialysis patients. Yonsei Med J 1998; 39: 116–21.
Kim BS, Park JH, Shin YS et al The incidence and clinical impact of hepatitis G virus infection in peritoneal dialysis and haemodialysis patients. Petit Dial Int 1998; 18 (suppl. 2): S12.
McLigeyo SO. Initial experience with CAPD in patients with HIV infection in a developing country. Petit Dial Int 1992; 12: 267–8.
Abraham G, Ravi R, Venkat R et al Successful use of CAPD as ESRD treatment in a HIV patient. JAPI 1994; 42: 828–9.
Honda M, Iitika K, Kawaguchi H et al The Japanese National Registry data on pediatric CAPD patients: a ten year experience. A report of the study group of Pediatric PD conference. Petit Dial Int 1996; 16: 269–75.
Chiou YH, Chen WP, Lin CY. Continuous ambulatory peritoneal dialysis for children with end stage renal disease. Chung Hua Min Kuo Hsiao Erh Ko I Hsueh Hui Tsa Chih 1990; 31: 280–7.
Munoz-Arizpe R, Salazar-Gutierrez ML, Gordillo-Paniagua G. Adequacy of chronic peritoneal dialysis in low socio economic class uremic children. Int J Pediatr Nephrol 1986; 7: 81–4.
Bahat E, Akman S, Ozcan S et al CAPD adaptation period and the relationship with the peritonitis rate in children. Petit Dial Int 1998; 18 (suppl. 2): S57.
Abraham G, Padma G, Mattew M, Shroff S. Ambulatory peritoneal dialysis in children: our experience. Ind J Perit Dial 1998; 1: 57.
Mirza K, Elzonki AY. Peritonitis in continuous ambulatory peritoneal dialysis in children living in Saudi Arabia. Pediatr Nephrol 1997; 11: 325–7.
Araki Y, Hataya H, Tanaka Y et al High incidence of peritoneal dialysis sclerosis in children in long term PD. Petit Dial Int 1998; 18 (suppl. 2): S54.
Kohli HS, Arora P, Kher V et al Daily peritoneal dialysis using a surgically placed Tenckhoff catheter for acute renal failure in children. Renal Failure 1995; 17: 51–56.
Kim JH, Kim PK. Clinical study of continuous ambulatory peritoneal dialysis (CAPD) and acute peritoneal dialysis in children. Petit Dial Int 1998; 18 (suppl. 2): S57.
Chan MK, Lam SS, Chin KW. Continuous ambulatory peritoneal dialysis (CAPD) in diabetic patients with end stage renal failure in Hong Kong. J Diabet Compli 1987; 1: 11–15.
Wei SS, Lee GS, Woo KT, LiM CH. Continuous ambulatory peritoneal dialysis in Type II diabetics Ann Acad Med Singapore 1993; 22: 629–33.
Lee HB. Dialysis in patients with diabetic nephropathy: CAPD vs HD. Petit Dial Int 1996; 16 (suppl. 1): S269–74.
Wu MS, Yu CC, Wu CH et al Predialysis glycemic control is an independent predictor of mortality in type II diabetic patient on CAPD. Petit Dial Int 1998; 18 (suppl. 2): S10.
Young GA, Kopple JB, Lindholm B et al Nutritional assessment of CAPD patients: an interpersonal study. Am J Kidney Dis 1991; 17: 462–71.
Guo D, Wang G, Jiang Y. Assessment of the nutritional status in 52 cases of CAPD patients. Petit Dial Int 1998; 18 (suppl. 2): S53.
Harty J, Gokal R. Nutritional status in PD. J Renal Nutr 1995; 5: 2–10.
Pinlac G, Danguclan RA. Nutritional parameters in new CAPD gpatients. Petit Dial Int 1998; 18 (suppl. 2): S52.
Jayanthi V, Ravichandran P, Abraham G. Nutritional problems in patients on CAPD. Petit Dial Int 1998; 18 (suppl. 2): 549.
Hong D: Nutritional status in CAPD patients. Perit Dial Int 1998; 18 (suppl. 2): S52.
Yuan B, Zhang Y, Chen X et al The influence of dietary management on nutritional status in continuous ambulatory peritoneal dialysis patients. Petit Dial Int 1998; 18 (suppl. 2): S51.
Chen TP, Lee HP. Oral nutritional supplement improves nutritional status of CAPD patients. Petit Dial Int 1998; 18 (suppl. 2): S50.
Kong W. Clinical observation of CAPD patients nutritional condition in the use of Chinese traditional medicine. Petit Dial Int 1998; 18 (suppl. 2): S52.
Kumar R, Abraham G, Padma G et al Peritoneal equilibration test in a CAPD population. Ind J Petit Dial 1998; 1: 34–6.
Naga SS, El-Belbessi A. Peritoneal equilibration test (PET) in acute peritoneal dilaysis (APD). Perit Dial Int 1998; 18 (suppl. 2): S3.
Sirivongs D, Chunlertrith D, Seetaso K. A modified PET for small size CAPD patients. Petit Dial Int 1998; 18 (suppl. 2): S3.
Wang NS, Tong LQ, Gao XP et al Clinical use of PET. Kt/V and PCR in peritoneal dialysis patients. Petit Dial Int 1998; 18 (suppl. 2): S6.
Lye WC, vander Straaten JC, Leong SO et al A cross sectional study on adequacy of dialysis, peritoneal equilibration test and nutrition in Asian CAPD patients. Petit Dial Int 1998; 18 (suppl. 2): S3.
Park JH, Koh SH, Kim BS et al Reference range of values of peritoneal equilibration test and changes in peritoneal kinetics in long term Korean patients. Petit Dial Int 1998; 18 (suppl. 2): S61.
Cueto-Manzano AM, Gamba G, Abasta-Jimenez M, Correa-Rotter R. Consistency of the peritoneal equilibration test in a cohort of non selected Mexican CAPD patients. Adv Petit Dial 1995; 11: 114–18.
Chu WS, Yi HA, Kim YH et al Peritoneal membrane hyper-permeability is a risk factor for CAPD mortality. Petit Dial Int 1998; 18 (suppl. 2): S10.
Lee IH, Kim BS, Hwang JH et al Serial changes of serum albumin according to the peritoneal membrane transport characteristics in long term CAPD patients. Petit Dial Int 1998; 18 (suppl. 2): S11.
Peers E, Gokal R. Icodextrin: overview of clinical experience. Perit Dial Int 1997; 17: 22–6.
Szeto CC, Lai KN, Yu AW et al Dialysis adequacy of Asian patients receiving small volume continuous ambulatory peritoneal dialysis. Int J Artif Organs 1997; 20: 428–35.
Lye WC, vander Straaten JC, Leong SD et al A cross sectional study on adequacy of dialysis, peritoneal equilibration test and nutrition in Asian CAPD patients. Perit Dial Int 1998; 18 (suppl. 2): S3.
Kim YL, Kim JH, Kim SJ et al Nutrition and dialysis adequacy of Korean patients on long term continuous ambulatory peritoneal dialysis. Perit Dial Int 1998; 18 (suppl. 2): S3.
Noh HT, Shin SK, Kang SW et al Impact of dialysis dose on clinical outcomes in Korean continuous ambulatory peritoneal dialysis (CAPD) patients. Perit Dial Int 1998; 18 (suppl. 2): S-1.
Okada K, Takahashi S, Higuchi T et al How long can continuous ambulatory peritoneal dialysis be continued? Nippon Jinzo Gokkai Shi 1993; 35: 65–71.
Kawaguchi Y, Hasegava T, Kubo H et al Current issues of continuous ambulatory peritoneal dialysis. Artif Organs 1995; 19: 1204–9.
Zent R, Myers JE, Donald D, Rayner BL. Continuous ambulatory peritoneal dialysis: an option in the developing world? Perit Dial Int 1994; 14: 48–51.
Ye RG, Lu CS, Li HQ. Survival probability and multivariate analysis of prognostic factors in CAPD patients. Perit Dial Int 1998; 18 (suppl. 2): S11.
Palanirajan S, Prakash KC. Dropouts in continuous ambulatory peritoneal dialysis in India since 1993: a single centre experience. Perit Dial Int 1998; 18 (suppl. 2): S22.
Aparajitha C, Chaitanya C, Abraham G et al Causes of dropout from CAPD in a developing country. Perit dial Int 1998; 18 (suppl. 2): S24.
Lo WK, Lo LY, Cheng SW et al Early commencement of dialysis is important for better CAPD patient survival. Perit Dial Int 1998; 18 (suppl. 2): S2.
Kobayashi H, Kasai K, Terawaki H et al Significance of residual renal functions of patients with end stage renal failure undergoing continuous ambulatory peritoneal dialysis. Nippon Jinzo Gakki Shi 1997; 39: 783–9.
Kawaguchi Y, Hasegawa T, Nakayama M et al Issues affecting the longevity of continuous ambulatory peritoneal dialysis therapy. Kidney Int 1997; 62: S105–7.
Wang T, Lin B, Ye RG. Comparison of quality of life in continuous ambulatory peritoneal dialysis and hemodialysis patients. Chung Hua Nei Ko Tsa Chi 1993; 32: 754–6.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Abraham, G., Gupta, A. (2000). Peritoneal dialysis in developing countries. In: Gokal, R., Khanna, R., Krediet, R.T., Nolph, K.D. (eds) Textbook of Peritoneal Dialysis. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-3225-3_29
Download citation
DOI: https://doi.org/10.1007/978-94-017-3225-3_29
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-017-3227-7
Online ISBN: 978-94-017-3225-3
eBook Packages: Springer Book Archive